Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 429.20
-8.30 (-1.90%)
Aug 10, 2026, 4:59 PM CET
Coloplast Financials Overview
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | 28,045 | 27,874 | 27,030 | 24,500 | 22,579 | 19,426 |
Revenue Growth | 0.90% | 3.12% | 10.33% | 8.51% | 16.23% | 4.76% |
Gross Profit Gross Profit Growth | 18,919 | 18,945 | 18,269 | 16,328 | 15,529 | 13,313 |
Operating Income Operating Income Growth | 4,166 | 7,201 | 7,320 | 6,771 | 6,439 | 6,155 |
Net Income Net Income Growth | 2,106 | 3,636 | 5,052 | 4,783 | 4,706 | 4,825 |
Earnings Per Share EPS Growth | 9.34 | 16.13 | 22.46 | 22.20 | 22.11 | 22.63 |
EPS Growth | -53.72% | -28.18% | 1.17% | 0.41% | -2.30% | 15.05% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Ostomy Care Ostomy Care Growth | 9,969 | 9,897 | 9,545 | 9,024 | 8,620 | 7,841 |
Continence Care Continence Care Growth | 9,133 | 8,984 | 8,540 | 7,958 | 7,643 | 7,003 |
Voice and Respiratory Care Voice and Respiratory Care Growth | 2,335 | 2,280 | 2,110 | 1,939 | 1,203 | - |
Interventional Urology Interventional Urology Growth | 2,819 | 2,784 | 2,775 | 2,674 | 2,424 | 2,097 |
Advanced Wound Dressings Advanced Wound Dressings Growth | 2,560 | 2,675 | 3,034 | 2,830 | 2,689 | 2,485 |
Biologics Biologics Growth | 1,229 | 1,254 | 1,026 | 75 | - | - |
Revenue (Total) Revenue (Total) Growth | 28,045 | 27,874 | 27,030 | 24,500 | 22,579 | 19,426 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 1,067 | 947 | 788 | 911 | 633 | 674 |
Total Debt Total Debt Growth | 24,228 | 22,639 | 22,629 | 19,567 | 18,708 | 2,786 |
Net Cash (Debt) Net Cash Growth | -23,161 | -21,692 | -21,841 | -18,656 | -18,075 | -2,112 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -102.82 | -96.24 | -97.11 | -86.57 | -84.94 | -9.91 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 7,595 | 6,645 | 2,766 | 4,226 | 5,099 | 5,290 |
Capital Expenditures CapEx Growth | -1,524 | -1,306 | -1,166 | -1,020 | -927 | -919 |
Free Cash Flow Free Cash Flow Growth | 6,071 | 5,339 | 1,600 | 3,206 | 4,172 | 4,371 |
Free Cash Flow Growth | 20.72% | 233.69% | -50.09% | -23.15% | -4.55% | 11.71% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Gross Margin | 67.46% | 67.97% | 67.59% | 66.64% | 68.78% | 68.53% |
Operating Margin | 14.85% | 25.83% | 27.08% | 27.64% | 28.52% | 31.68% |
Pretax Margin | 12.28% | 22.09% | 23.66% | 24.59% | 27.14% | 32.09% |
Profit Margin | 7.51% | 13.04% | 18.69% | 19.52% | 20.84% | 24.84% |
FCF Margin | 21.65% | 19.15% | 5.92% | 13.09% | 18.48% | 22.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Dividend Per Share Dividend Per Share Growth | 23.000 | 23.000 | 22.000 | 21.000 | 20.000 | 19.000 |
Dividend Per Share Growth | 4.55% | 4.54% | 4.76% | 5.00% | 5.26% | 5.56% |
Dividend Yield | 5.26% | 4.05% | 2.40% | 2.64% | 2.45% | 1.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
PE Ratio | 46.83 | 33.66 | 38.96 | 33.68 | 35.09 | 44.48 |
Forward PE | 17.27 | 21.87 | 35.61 | 27.34 | 28.98 | 41.10 |
P/FCF Ratio | 16.23 | 22.92 | 123.23 | 52.39 | 39.48 | 49.00 |
PS Ratio | 3.51 | 4.39 | 7.29 | 6.86 | 7.29 | 11.03 |